Skip to content

We are a world-leading biotechnology investment firm
with three decades of experience creating and investing in innovative companies
seeking to deliver transformative therapies to patients.

At our core, we are company creators. Our dedicated team of Entrepreneur Partners provide deep domain expertise in research and development, intellectual property, clinical strategy and commercialization – elements that we believe are crucial for successful company building.

MPM BioImpact combines the 30+ year track record of the MPM CAPITAL® services and offerings in biotech venture capital with BioImpact’s dedication to impact and 10+ years of public investing. Together, we manage over $3 billion AUM across early-stage venture funds, private/public impact funds and a public equities fund.


We are proud to be committed to the Global Standards for managing impact investments.

Signatory to:

Learn more about our affiliate, BioImpact Capital